EU’s Industrial Forum, the future of advanced manufacturing technologies
by Giuliana Miglierini The expert group “Industrial Forum” is a multistakeholder body created by the European Commission to…
The debate on the “Do No Significant Harm” principle in R&D
by Giulianna Miglierini The “Do No Significant Harm” (DNSH) principle is a widely diffused approach aimed to guarantee…
Trends for the future of the pharmaceutical manufacturing
By Giuliana Miglierini The technological evolution of pharmaceutical manufacturing towards the full implementation of the Industry 4.0 paradigm…
ECA’s guide to compliant equipment design
By Giuliana Miglierini The legislative evolution of the last decades emphasised requirements for equipment used in pharmaceutical productions.…
HERA reports on stockpiling of antimicrobials
By Giuliana Miglierini The European Health Emergency Preparedness and Response Authority (HERA) has published the two final reports,…
Some perspectives on green pharmaceuticals
by Giuliana Miglierini The central role the green agenda plays within the EU Commission’s transformative policies impacts also…